Inc. (Nasdaq: NKGN) (“NKGen” or the “Company”), a clinical-stage biotechnology company focused on the development and commercialization of innovative autologous and allogeneic natural killer cell ...
Following the conference, the presentations presented at the 29 th Annual Congress of the WMS will be available on the Investors page of PepGen’s website under Scientific Publications.
National University Corporation OITA UNIVERSITY ("Oita University") and Hitachi High-Tech Corporation ("Hitachi High-Tech") today announced that we have started conducting research ("this research") ...
Iterum Therapeutics plc (Nasdaq: ITRM) (the Company), a clinical-stage pharmaceutical company focused on developing next generation oral and IV antibiotics to treat infections caused by multi-drug ...
Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) ("Alterity” or "the Company”), a biotechnology company dedicated to developing disease modifying treatments for neurodegenerative diseases, today ...